Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine
University of Chicago · University of Chicago Medical Center · +5 more institutions
Abstract
Gene therapies. There has been a long-lasting interest in using viral vectors, especially adenoviral vectors, to deliver therapeutic genes for the past two decades. Among all currently available viral vectors, adenovirus is the most efficient gene delivery system in a broad range of cell and tissue types. The applications of adenoviral vectors in gene delivery have greatly increased in number and efficiency since their initial development. In fact, among over 2,000 gene therapy clinical trials approved worldwide since 1989, a significant portion of the trials have utilized adenoviral vectors. This review aims to provide a comprehensive overview on the characteristics of adenoviral vectors, including adenoviral…
Citation impact
- FWCI
- 40.21
- Percentile
- 100%
- References
- 281
Authors
22- CLCody LeeCorresponding
University of Chicago, University of Chicago Medical Center, Molecular Oncology (United States)
- ESElliot S. Bishop
University of Chicago Medical Center
- RZRuyi Zhang
University of Chicago Medical Center, Molecular Oncology (United States), Chongqing Medical University
- XYXinyi Yu
University of Chicago Medical Center, Molecular Oncology (United States), Chongqing Medical University
- EMEvan M. Farina
University of Chicago, University of Chicago Medical Center, Molecular Oncology (United States)
Topics & keywords
- Genetic enhancement
- Viral vector
- Gene delivery
- Personalized medicine
- Clinical trial
- Vector (molecular biology)
- Computational biology
- Medicine
Funding
- UDU.S. Department of DefenseAward: OR130096
- SRScoliosis Research Society
- UOUniversity of ChicagoAward: P30CA014599
- MOMinistry of Science and Technology of the People's Republic of ChinaAward: 2011CB707906
- CSChina Scholarship Council
- NINational Institutes of HealthAwards: DE020140, AT004418
- NKNational Key Research and Development Program of China
- NINational Institute of Diabetes and Digestive and Kidney Diseases
- NCNational Center for Advancing Translational SciencesAward: UL1 TR000430